Chronic myelomonocytic leukaemia (Q39195): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
Neoplasia mielodisplásica / mieloproliferativa caracterizada por monocitose persistente, ausência de cromossoma Philadelphia e gene de fusão BCR/ABL1, contagem de blastos menor do que 20% na medula óssea e no sangue, frequentemente mielodisplasia e ausência de rearranjo do PDGFRA (platelet-derived growth factor receptor alfa - receptor do fator de crescimento plaquetário alfa) ou PDGFRB (platelet-derived growth factor receptor beta - receptor do fator de crescimento plaquetário beta). | |||
| description / en | description / en | ||
A myelodysplastic/myeloproliferative neoplasm which is characterised by persistent monocytosis, absence of a Philadelphia chromosome and BCR/ABL1 fusion gene, fewer than 20 percent blasts in the bone marrow and blood, often myelodysplasia, and absence of PDGFRA or PDGFRB rearrangement. | |||
Revision as of 04:32, 13 August 2026
A myelodysplastic/myeloproliferative neoplasm which is characterised by persistent monocytosis, absence of a Philadelphia chromosome and BCR/ABL1 fusion gene, fewer than 20 percent blasts in the bone marrow and blood, often myelodysplasia, and absence of PDGFRA or PDGFRB rearrangement.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 2A40 |
||
| English | Chronic myelomonocytic leukaemia |
A myelodysplastic/myeloproliferative neoplasm which is characterised by persistent monocytosis, absence of a Philadelphia chromosome and BCR/ABL1 fusion gene, fewer than 20 percent blasts in the bone marrow and blood, often myelodysplasia, and absence of PDGFRA or PDGFRB rearrangement. |
